Creating a technology to verify engineered DNA molecules

Development of a technology to certify engineered DNA molecules

['FUNDING_R01'] · COLORADO STATE UNIVERSITY · NIH-10911123

This study is working on a new way to securely track and verify DNA tools called plasmids, which are important for scientists in research and medicine, so they can be sure they’re using the right genetic information for things like gene therapy and vaccines.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCOLORADO STATE UNIVERSITY (nih funded)
Locations1 site (FORT COLLINS, UNITED STATES)
Trial IDNIH-10911123 on ClinicalTrials.gov

What this research studies

This research focuses on developing a new digital certification technology for engineered DNA molecules, particularly plasmids, which are crucial tools in biological research and clinical applications. The project aims to address issues related to the authentication and documentation of plasmids, ensuring that researchers can reliably connect physical samples to their genetic information. By creating a secure, standardized approach to documenting plasmid sequences and functions, this research seeks to enhance reproducibility and safety in biotechnology applications, ultimately benefiting gene therapy and vaccine development.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include individuals involved in gene therapy, vaccine development, or those requiring recombinant drugs.

Not a fit: Patients who are not engaged in or do not require advanced genetic therapies or biotechnology applications may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve the reliability and safety of genetic research and therapies, leading to better patient outcomes.

How similar studies have performed: While the approach of digital certification for biological materials is innovative, similar efforts in improving documentation and authentication in biotechnology have shown promise in enhancing research reliability.

Where this research is happening

FORT COLLINS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.